Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study
| Image |  |
|---|---|
| Description | scientific article published on 01 September 2018 |
| Author/s |
author: Richard Greil Franz Josef Gassner Lisa Pleyer Nadja Zaborsky Tanja N Hartmann |
| Publication date | September 1, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |